Natus Medical (BABY) EPS Estimated At $0.70; Bright Scholar Education Holding (BEDU) Shorts Down By 13.33%

January 14, 2018 - By Marguerite Chambers

Bright Scholar Education Holding (NYSE:BEDU) had a decrease of 13.33% in short interest. BEDU’s SI was 809,700 shares in January as released by FINRA. Its down 13.33% from 934,200 shares previously. With 324,700 avg volume, 3 days are for Bright Scholar Education Holding (NYSE:BEDU)’s short sellers to cover BEDU’s short positions. The stock increased 5.05% or $1.15 during the last trading session, reaching $23.91. About 334,607 shares traded or 7.96% up from the average. Bright Scholar Education Holdings Limited (NYSE:BEDU) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts expect Natus Medical Incorporated (NASDAQ:BABY) to report $0.70 EPS on February, 7.They anticipate $0.19 EPS change or 37.25% from last quarter’s $0.51 EPS. BABY’s profit would be $21.45 million giving it 10.34 P/E if the $0.70 EPS is correct. After having $0.40 EPS previously, Natus Medical Incorporated’s analysts see 75.00% EPS growth. The stock decreased 0.17% or $0.05 during the last trading session, reaching $28.95. About 862,791 shares traded or 81.27% up from the average. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since January 14, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

Bright Scholar Education Holdings Limited operates K-12 schools in the PeopleÂ’s Republic of China. The company has market cap of $2.80 billion. The Company’s schools comprise international schools, bilingual schools, and kindergartens. It has a 94.51 P/E ratio. The firm also offers a range of complementary education services, including international camps and after-school programs.

Investors sentiment decreased to 0.76 in Q3 2017. Its down 0.41, from 1.17 in 2017Q2. It fall, as 32 investors sold Natus Medical Incorporated shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported. Prudential Fincl, New Jersey-based fund reported 207,161 shares. 1492 Cap reported 24,137 shares or 0.8% of all its holdings. 867,337 were reported by State Street. Hanson Doremus Investment holds 1,200 shares or 0.02% of its portfolio. State Board Of Administration Of Florida Retirement Sys stated it has 25,390 shares or 0% of all its holdings. Ny State Common Retirement Fund stated it has 0% in Natus Medical Incorporated (NASDAQ:BABY). Swiss Comml Bank reported 54,100 shares. Geode Mgmt Ltd Llc holds 0% or 289,266 shares. Mutual Of America Cap Management Limited Liability Corporation, New York-based fund reported 1,450 shares. Ubs Asset Management Americas stated it has 16,127 shares. Northwestern Mutual Wealth reported 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY). Dekabank Deutsche Girozentrale holds 13,000 shares. Goldman Sachs Inc owns 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 103,992 shares. Inv Management Of Virginia, a Virginia-based fund reported 68,808 shares. State Of Tennessee Treasury Department owns 29,269 shares for 0.01% of their portfolio.

Since August 14, 2017, it had 0 buys, and 2 sales for $257,048 activity. 3,000 shares valued at $102,300 were sold by MOORE WILLIAM M on Monday, August 14. $154,748 worth of Natus Medical Incorporated (NASDAQ:BABY) was sold by GUNST ROBERT A on Thursday, September 14.

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical had 10 analyst reports since July 23, 2015 according to SRatingsIntel. As per Tuesday, April 5, the company rating was maintained by Roth Capital. The firm earned “Hold” rating on Monday, January 8 by William Blair. Roth Capital maintained Natus Medical Incorporated (NASDAQ:BABY) on Friday, June 23 with “Buy” rating. TH Capital maintained the stock with “Buy” rating in Thursday, October 22 report. Raymond James downgraded the stock to “Mkt Perform” rating in Thursday, February 2 report. The firm has “Buy” rating by TH Capital given on Thursday, July 23. TH Capital maintained Natus Medical Incorporated (NASDAQ:BABY) rating on Tuesday, January 12. TH Capital has “Buy” rating and $50.0 target. Benchmark initiated Natus Medical Incorporated (NASDAQ:BABY) rating on Tuesday, October 4. Benchmark has “Buy” rating and $55 target. Raymond James upgraded the stock to “Outperform” rating in Tuesday, September 13 report. On Monday, September 11 the stock rating was maintained by Roth Capital with “Buy”.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $887.13 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The company??s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News